| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 115.22B | 112.79B | 112.04B | 105.16B | 98.82B | 92.94B |
| Gross Profit | 15.81B | 15.07B | 16.48B | 14.49B | 14.39B | 13.55B |
| EBITDA | 8.44B | 7.81B | 9.54B | 7.75B | 8.86B | 8.14B |
| Net Income | -4.07B | -4.19B | 1.75B | 400.00M | 621.00M | 301.00M |
Balance Sheet | ||||||
| Total Assets | 120.36B | 122.34B | 119.46B | 113.77B | 114.38B | 113.73B |
| Cash, Cash Equivalents and Short-Term Investments | 18.78B | 19.95B | 21.11B | 16.95B | 20.25B | 21.31B |
| Total Debt | 25.73B | 26.11B | 22.68B | 22.81B | 25.46B | 28.34B |
| Total Liabilities | 52.27B | 53.05B | 46.87B | 46.69B | 48.07B | 49.39B |
| Stockholders Equity | 67.47B | 68.67B | 72.01B | 66.58B | 65.79B | 63.73B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -3.82B | 4.62B | 200.00M | 2.49B | 559.00M |
| Operating Cash Flow | 0.00 | 6.25B | 10.74B | 5.87B | 7.10B | 5.64B |
| Investing Cash Flow | 0.00 | -10.20B | -6.22B | -5.84B | -4.72B | -5.13B |
| Financing Cash Flow | 0.00 | 2.07B | -1.01B | -4.03B | -3.73B | 8.54B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥26.18B | 14.38 | ― | 4.20% | -1.15% | -34.09% | |
64 Neutral | ¥92.48B | 2.18 | ― | 1.61% | 6.81% | 6.68% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥3.98B | 10.35 | ― | 3.03% | 4.17% | -693.96% | |
59 Neutral | ¥41.20B | 50.47 | ― | 5.35% | -6.20% | -64.65% | |
51 Neutral | ¥30.96B | 12.50 | ― | 2.45% | 4.93% | ― | |
47 Neutral | ¥25.08B | -5.63 | ― | 3.33% | -3.91% | -36.53% |